Different infusion durations for preventing platinum‐induced hearing loss in children with cancer

Since only one eligible RCT evaluating the use of a continuous cisplatin infusion vs. 1‐hour bolus cisplatin infusion was found, and that had methodological limitations, no definitive conclusions could be made.

Source:

Cochrane Database of Systematic Reviews